Refine by
Infections And Protecting Articles & Analysis
18 news found
The agency goes so far as to advise physicians to keep invasive mold infections in mind when treating people who are sick after exposure to mold following a flood. Groups listed by CDC as being at elevated risk of developing invasive mold infections include those who: · Have had a transplant, especially hematopoietic stem cell transplants ...
Mucormycosis is a rare but serious type of fungal infection caused by a group of fungi known as mucormycetes. Mucor species and Rhizopus species are some of the most common causes of mucormycosis, however there are also other species. The fungi typically live in soil and decaying organic matter. It is frequently a life-threatening infection warns the Centers for Disease Control and Prevention ...
People of all ages are susceptible to getting infected and sick with norovirus. According to the Centers for Disease Control and Prevention (CDC), it is the leading cause of vomiting and diarrhea, and foodborne illness in the United States. The agency also warns that infection with one type of norovirus may not protect an individual against other ...
Proper treatment is essential to prevent the spread of infections and protect both public health and the environment. Refractory materials and silica refractory brick properties step in as critical components in the incineration process, providing the necessary linings for high-temperature furnaces.Heat-Resistant Furnace LiningsIncineration is a widely adopted ...
Therefore, when the more transmissible Omicron BA.1 sublineage hit back in February, population immunity from infection was low. This, combined with a low vaccine coverage, led to a huge wave of both infections and deaths, especially amongst the elderly. ...
In addition to SER-109, SER-155 represents Seres’ second active development program in its Infection Protection franchise. Another poster presentation on June 4 at 1:15-4:15 PM CDT will reprise Phase III trial results of SER-109, an investigational microbiome therapeutic for recurrentC.difficileinfection (rCDI). ...
“These results suggest that our investigational microbiome therapeutic, SER-109, is a potentially fast-acting intervention that can provide durable relief from recurrent C. difficile infections when administered to vulnerable patients,” said Matthew Henn, Ph.D., Chief Scientific Officer at Seres. ...
“Microbiome-based therapeutics have the potential to protect medically compromised transplant patients from life-threatening infections and GvHD as they start on their road to recovery,” said Matthew Henn, PhD, Chief Scientific Officer at Seres and co-author. ...
SER-109 is an investigational oral microbiome therapeutic for the prevention of recurrentC. difficile infection (rCDI). With an oral and poster presentation, Seres will present data on how SER-109 restores the functionality of the microbiome in a rapid and durable manner, which further supports the potential of microbiome therapeutics. ...
Preclinical activities are also underway for additional Infection Protection development candidates, leveraging our prior compelling clinical data in this therapeutic category, for indications such as cancer neutropenia, solid organ transplant, and antimicrobial resistant infections more broadly,” continued Mr. ...
(NASDAQ:CYTO), a company dedicated to addressing unmet medical needs through RNA therapeutics, allergy and viral infection protection, and inner ear therapeutics announced today that Bentrio™ has been approved by the Medical Device Authority of Malaysia and is, therefore, cleared for commercialization in that country. ...
(NASDAQ:CYTO), a company dedicated to addressing unmet medical needs through RNA therapeutics, allergy and viral infection protection, and inner ear therapeutics, today provided a business update on its development activities in RNA therapeutics. ...
BlueWillow’s rPA/NE01 anthrax vaccine, BW-1010, developed in collaboration with Porton Biopharma Limited (UK) and funded by the National Institute of Allergy and Infectious Diseases, is an intranasal recombinant protein vaccine candidate against anthrax with proven safety and immunogenicity data in humans that can potentially protect from infection, disease ...
The data demonstrate that a single adjuvant-free dose of MV-014-212 provided equivalent protection against SARS-CoV-2 challenge compared to reported efficacy in NHP models of currently authorized vaccines. ...
The British Occupational Hygiene Society, a scientific charity and the Chartered Society for Worker Health Protection has released a set of frequently asked questions on ventilation and COVID-19. ...
Mucus and other airway secretions surrounding influenza viruses when coughed or exhaled from infected individuals may protect the virus in the aerosol phase, even in high humidity environments. Laboratory tests using H1N1 flu viruses aerosolised alongside secretions from a human lung cell culture at a range of humidities showed that both the airborne viruses ...
In practice, that means good fertility, longer life, udders that give good protection against infections, improved claws and more efficient feed utilisation. ...
Their latest educational video discusses bacterial meningitis and the bacteria responsible for the infections. Meningitis is an infection of the protective membranes covering the brain and spinal cord. The condition can be caused by a viral, fungal or bacterial infection. Bacterial meningitis is caused by a number of ...